Related Experiment Videos
Cost-effectiveness of the AMOArray multifocal intraocular lens in cataract surgery
Michelle E Orme1, Abigail C Paine, Christopher W Teale
1Lewin Group, Action International House, Egham, Surrey, United Kingdom.
Purpose:
To compare the cost and outcomes of bilateral cataract surgery with the foldable AMOArray multifocal intraocular lens (MIOL) versus the foldable monofocal intraocular lens from the health care payer perspective.
Methods:
A cost-effectiveness analysis was used to evaluate treatment with the MIOL compared to monofocal lens, using data from clinical trials, literature, expert opinion, and a review of the German health care funding and reimbursement system.
Results:
The average total direct medical cost per patient (per procedure) with the MIOL was DM 1,774 compared to DM 1,716 with the monofocal lens (1DM = US$0.558 in April 1998). The MIOL was more cost-effective than the monofocal lens in terms of cost per patient (spectacle-free). Cost per patient without overall limitation in vision-related function and cost per patient without limited night vision were similar for both patient groups. The incremental cost of the MIOL for a one-point increase was DM 52 in the self-rated score "quality of vision," DM 82 in "satisfaction with day vision," and DM 115 in "satisfaction with night vision."
Conclusion:
The small additional cost of the MIOL was outweighed by the increased satisfaction with vision experienced by MIOL patients.